- Like, Share, or Comment:
Blog/Industry News
Fentanyl Adulteration and its Legal Implications
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Law Defense and Compliance Firm Introduction In a recent development that underscores the gravity of prescription drug...
Read More ›
Mandatory Transparency and Accountability: Massachusetts Governor Takes Decisive Action Against Steward...
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Law Defense and Compliance Firm In a significant development that underscores the importance of financial transparency and accountability in the healthcare...
Read More ›
Strengthening Healthcare Compliance and Cybersecurity: Insights from the Latest HIPAA Security...
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Law Defense and Compliance Firm The healthcare sector is witnessing a pivotal moment in the evolution of cybersecurity and compliance...
Read More ›
Navigating the Complexities of Telemedicine DME Fraud: A $110 Million Cautionary...
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Law Defense and Compliance Firm In a recent revelation that underscores the intricate challenges facing the healthcare sector, particularly in the realm of...
Read More ›
Navigating the FDA’s Legal Landscape of Medical Device Marketing: The InMode...
By: Christopher A. Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Law Defense and Compliance Firm InMode Ltd., a prominent cosmetic medical device manufacturer, is currently embroiled in a legal battle over...
Read More ›
The Final Rule on Confidentiality of Substance Use Disorder Patient Records...
By: Christopher Parrella, ESQ., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Care Defense and Compliance Firm On February 8, 2024, a significant regulatory shift occurred that promises to redefine the landscape of substance use...
Read More ›